| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Interleukin-1 receptor-associated kinase 4 |
|---|
| Ligand | BDBM203804 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | IMAP technology (Molecular Devices) |
|---|
| pH | 7.2±n/a |
|---|
| Temperature | 298.15±n/a K |
|---|
| IC50 | 2±n/a nM |
|---|
| Comments | extracted |
|---|
| Citation |  Seganish, WM; Brumfield, SN; Lim, J; Matasi, JJ; McElroy, WT; Tulshian, DB; Lavey, BJ; Altman, MD; Gibeau, CR; Lampe, JW; Methot, J; Zhu, L Aminopyrimidinones as interleukin receptor-associated kinase inhibitors US Patent US9221809 Publication Date 12/29/2015 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Interleukin-1 receptor-associated kinase 4 |
|---|
| Name: | Interleukin-1 receptor-associated kinase 4 |
|---|
| Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 51519.08 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q9NWZ3 |
|---|
| Residue: | 460 |
|---|
| Sequence: | MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALL
QTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITV
QQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNF
DERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC
QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN
FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL
RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND
ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
|
|
|
|---|
| BDBM203804 |
|---|
| n/a |
|---|
| Name | BDBM203804 |
|---|
| Synonyms: | US9221809, 355 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H36N8O2S |
|---|
| Mol. Mass. | 524.681 |
|---|
| SMILES | N[C@H]1CCCC[C@H]1Nc1cccc2sc(nc12)-c1c(N[C@@H]2CCCNC2)nc([nH]c1=O)N1CCOCC1 |r| |
|---|
| Structure | 
|
|---|
Search and Browse
